What Is Interstitial Cystitis?

Interstitial cystitis (IC), also called bladder pain syndrome, is a chronic condition characterized by pain or discomfort perceived as related to the bladder, accompanied by urinary urgency and increased frequency, in the absence of infection or another identifiable cause.

It predominantly affects women (5:1 ratio), with an estimated prevalence of 2-5% in the female population. Diagnosis is often delayed — symptoms typically persist for 4-7 years before a correct diagnosis, during which patients are repeatedly treated for urinary infections that are never confirmed.

IC is a chronic pain condition that shares central sensitization mechanisms with fibromyalgia, irritable bowel syndrome, and chronic pelvic pain. Overlap with these conditions is common, suggesting a shared vulnerability to central sensitization syndromes.

1

Urothelial Barrier Dysfunction

Loss of the protective GAG (glycosaminoglycan) layer from the urothelium lets irritating urinary solutes penetrate the bladder submucosa.

2

Central Sensitization

Chronic bladder pain sensitizes nociceptive pathways, amplifying pain perception and producing referred pain in the pelvis, perineum, and abdomen.

3

Diagnosis of Exclusion

Diagnosis requires ruling out urinary infection, bladder cancer, endometriosis, overactive bladder, and other causes of similar symptoms.

Pathophysiology

The pathophysiology of IC is multifactorial. The most accepted theory involves urothelial barrier dysfunction: the layer of glycosaminoglycans (GAG) that lines the urothelium is defective, allowing potassium, urea, and other urinary solutes to penetrate the submucosa, activating mast cells and nociceptive fibers.

Mast cells play a central role, releasing histamine, tryptase, substance P, and inflammatory cytokines in the bladder wall. The resulting neurogenic inflammation activates and sensitizes C afferent fibers, which transmit pain and urgency signals to the sacral segments and higher centers.

Over time, central sensitization sets in: neurons of the dorsal horn of the spinal cord become hyper-responsive, descending inhibitory modulation diminishes, and cortical áreas of pain processing are reorganized. This explains pain amplification, bladder allodynia (pain with normal filling), and pain expansion to neighboring áreas (perineum, abdomen, vulva).

Phenotypes of Interstitial Cystitis

PhenotypeFeaturesPrincipal MechanismTherapeutic Response
Hunner ulcer (10-20%)Ulcerative lesions in the bladder mucosa, reduced capacityFocal inflammation with lymphocytic infiltrateFulguration/injection of the lesion, cyclosporine
Non-ulcerative (80-90%)Glomerulations on cystoscopy, no focal lesionBarrier dysfunction, neural sensitizationMultimodal treatment, neuromodulation
Associated with central sensitizationOverlap with fibromyalgia, IBS, vulvodyniaPredominant central sensitizationChronic pain approach, neuromodulation
2-5%
estimated prevalence in women
5:1
female-to-male ratio
4-7 years
average time to correct diagnosis
80-90%
of cases are non-ulcerative phenotype

Symptoms

The classic triad is pelvic/bladder pain, urinary urgency, and increased frequency. Pain typically worsens with bladder filling and is partially relieved by urination. Symptoms fluctuate in flares and remissions, with exacerbations associated with specific foods, stress, and the menstrual cycle.

Clinical Picture of Interstitial Cystitis

  • Suprapubic pain that worsens with bladder filling

    Suprapubic pain, pressure, or discomfort that intensifies as the bladder fills and partially eases after voiding. May radiate to the perineum, vagina, rectum, and urethra.

  • Extreme urinary frequency

    Patients may urinate 20-60 times a day in severe cases, passing very small volumes (50-100 mL). The frequency is driven by the need to keep the bladder empty and avoid pain.

  • Painful urinary urgency

    Unlike OAB, urgency in IC is often accompanied by pain. The patient urinates not only from urgency but to relieve mounting discomfort.

  • Severe nocturia

    Waking multiple times at night to urinate is common. Nocturia in IC is often driven by pain, not just urgency, causing severe sleep deprivation.

  • Exacerbation by foods and beverages

    Caffeine, alcohol, citrus, tomato, artificial sweeteners, and spicy foods often worsen symptoms. An elimination diet can identify individual triggers.

  • Dyspareunia and pelvic pain

    Pain during or after intercourse is very common. Pelvic pain may broaden to include vulvodynia, rectal pain, and pelvic floor musculoskeletal pain.

Diagnosis

The diagnosis of IC is one of exclusion: it requires ruling out urinary infection, carcinoma in situ, bladder endometriosis, bladder stone, and overactive bladder. Cystoscopy with hydrodistension can identify glomerulations and Hunner ulcer but is not mandatory for diagnosis.

Diagnostic Criteria

Source: AUA/SUFU and ESSIC Guidelines

Inclusion Criteria
  1. Bladder-related pain, pressure, or discomfort lasting > 6 weeks
  2. At least one urinary symptom: urgency and/or frequency
  3. Absence of urinary infection or other identifiable cause
  4. Symptoms must cause significant functional impact
Mandatory Exclusions
  1. Negative urine culture (repeat if necessary)
  2. Urinary cytology or cystoscopy if hematuria or risk of neoplasia
  3. Pelvic ultrasonography: rule out masses
  4. Gynecologic evaluation: rule out endometriosis and pelvic pathology
Complementary Evaluation
  1. Potassium sensitivity test (PST): a positive result suggests urothelial barrier dysfunction
  2. Cystoscopy with hydrodistension: identifies glomerulations and Hunner ulcer
  3. Bladder biopsy: confirms mastocytosis and inflammatory infiltrate
  4. Urodynamic study: distinguishes IC from overactive bladder (optional)

Differential Diagnosis

Urinary Tract Infection

  • Acute onset
  • Dysuria present
  • Positive urine culture
Warning signs
  • Fever and flank pain — pyelonephritis
Diagnostic testsUrine cultureUrinalysis

Not indicated during acute UTI; can treat residual hypersensitivity

Overactive Bladder

Read more
  • Urgency and frequency without painful component
  • Negative urine culture
  • No pain with full bladder
Diagnostic testsVoiding diaryCystoscopy if necessary

Neuromodulation for overactive bladder; specifically indicated to reduce urgency

Bladder Endometriosis

Read more
  • Urinary symptoms that worsen with menstruation
  • Catamenial hematuria
  • Woman of reproductive age
Warning signs
  • Cyclic hematuria — mandatory investigation
Diagnostic testsCystoscopyPelvic MRI

Modulates central sensitization and associated chronic pelvic pain

Bladder Cancer

  • Macroscopic hematuria
  • Persistent symptoms in older adults
  • Smoking as a risk factor
Warning signs
  • Macroscopic hematuria — urgent investigation
Diagnostic testsCystoscopy with biopsyCT

Has no role in oncologic treatment

Chronic Prostatitis (in men)

Read more
  • Perineal and pelvic pain in men
  • Obstructive and irritative voiding symptoms
  • Normal or mildly elevated PSA
Warning signs
  • Fever — acute bacterial prostatitis
Diagnostic testsPSAUrine and prostatic secretion culturesProstate ultrasonography

Neuromodulates chronic pelvic pain and reduces prostatic inflammation

Recurrent Urinary Tract Infection

Interstitial cystitis is often mistaken for recurrent UTI, causing diagnostic delays of several years. The key to the differential is simple: in IC, urine cultures are consistently negative. Women with recurring urinary symptoms and negative cultures should be investigated for IC before further antibiotic courses.

Beyond negative cultures, IC features pain as the central component — suprapubic or pelvic pain that progressively worsens as the bladder fills. This pain, typically relieved by voiding, is the clinical marker that distinguishes IC from OAB and UTI. A voiding diary that also records pain is a valuable diagnostic tool.

Bladder Endometriosis

Endometriosis affects the bladder in 1-2% of cases, producing cyclic urinary symptoms that worsen during menstruation — catamenial hematuria, urgency, and frequency that intensify around the cycle. This cyclic pattern distinguishes bladder endometriosis from IC, which is not tied to the menstrual cycle.

Cystoscopy can reveal endometriotic implants in the bladder mucosa, often with a characteristic blue-violet color. Pelvic MRI is the test of choice for surgical planning. Treatment is hormonal and, in cases with transmural involvement, surgical.

Overactive Bladder

Distinguishing IC from OAB is essential because the treatments differ. In OAB, the dominant symptom is urinary urgency with or without incontinence, without a significant pain component. In IC, pain is the central symptom — urgency without pain is unlikely in IC.

The Pelvic Pain and Urgency/Frequency (PUF) scale aids differentiation. High pain scores favor IC; dominant urgency without pain favors OAB. Many patients have a mixed picture, which requires a combined therapeutic approach.

Treatment

Treatment of IC is multimodal and individualized. There is no cure, but symptoms can be significantly controlled with a combination of approaches. The AUA stepwise approach guides progressive treatment.

First line — continuous
Education and Self-Care

Elimination diet (identify and avoid food triggers). Stress management. Pelvic relaxation techniques. Heat application. Adapted bladder training. Psychological support and support groups.

Second line — 3-6 months
Physical Therapy and Oral Therapy

Pelvic floor physical therapy with relaxation techniques (trigger points, stretching). Amitriptyline (10-75 mg) for neuropathic pain and improved sleep. Hydroxyzine (antihistamine). Pentosan polysulfate sodium (restores the GAG barrier).

Third line — cycles of 6-8 weeks
Intravesical Instillations

DMSO (dimethyl sulfoxide): intravesical anti-inflammatory and analgesic. Intravesical heparin + lidocaine. Intravesical hyaluronic acid (restores the GAG barrier). DMSO + heparin + bicarbonate + triamcinolone cocktail.

Refractory — multidisciplinary evaluation
Fourth-Line Treatments

Bladder hydrodistension (temporary therapeutic effect). Sacral neuromodulation. Fulguration or injection of Hunner ulcers. Intravesical botulinum toxin. Cyclosporine A for cases with Hunner ulcers.

The essentials so far
  1. Treatment of IC is multimodal and individualized.
  2. There is no cure, but symptoms can be significantly controlled with a combination of approaches.
  3. The AUA stepwise approach guides progressive treatment.
Continue: Acupuncture as Treatment

Acupuncture as Treatment

Acupuncture has been studied in IC as an intervention with the potential to act on multiple pathologic mechanisms — proposed mechanisms include pain modulation (involving the endogenous opioid system), reduction of neurogenic inflammation (with described modulation of substance P and CGRP in experimental models), and effect on central sensitization.

Points such as CV-3, CV-4, SP-6, BL-32, BL-33, and LR-3 are used to modulate bladder afferents, reduce mast cell hyperactivity, and promote pelvic floor relaxation. Electroacupuncture at sacral points can directly modulate the S2-S4 nerves that control bladder sensitivity.

Acupuncture also addresses components often overlooked in IC: stress, anxiety, sleep disturbances, and pelvic floor muscle tension. An integrative approach to IC that includes acupuncture aligns with the multidimensional nature of the condition.

Plate of point SP 6 Sanyinjiao
Point cited in this article
SP 6
Sanyinjiao 三陰交
Location
On the medial aspect of the leg, 3 cun above the most prominent point of the medial malleolus, in a depression near the posterior border of the medial crest of the tibia.

Prognosis

IC is a chronic condition with a fluctuating course. Spontaneous remissions occur in 30-50% of patients and may last months to years. Most patients achieve adequate symptom control with multimodal treatment, although complete cure is rare.

Prognosis is better when diagnosis is early, treatment is multimodal, and comorbidities (fibromyalgia, IBS, depression) are treated simultaneously. A patient-centered approach with active participation in management is associated with better long-term outcomes.

Myths and Facts

Myth vs. Fact

Myth

Interstitial cystitis is just chronic urinary infection.

Fact

IC is NOT caused by infection. Urine cultures are negative. The condition involves urothelial barrier dysfunction, neurogenic inflammation, and central sensitization. Repeated antibiotics are ineffective and cause unnecessary adverse effects.

Myth vs. Fact

Myth

There is no effective treatment for IC.

Fact

Although there is no cure, multiple treatments can improve symptoms: diet, physical therapy, oral medications, intravesical instillations, and neuromodulation; acupuncture can be used as a complement, with limited evidence. A multimodal approach gives most patients adequate control.

Myth vs. Fact

Myth

IC is a psychosomatic disease.

Fact

IC has a well-established pathophysiologic basis: GAG barrier dysfunction, mastocytosis, neurogenic inflammation, and central sensitization. It is a real chronic pain condition with demonstrable mechanisms, not a psychological manifestation.

When to Seek Help

Frequently Asked Questions